Sellas Life Sciences Group - Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SLS•Arbitrator dismisses Sellas claims against 3D Medicines
July 27 (Reuters) - Sellas Life Sciences Group Inc SLS.O:
- Sellas Life Sciences Group - Arbitrator dismisses company's claims in arbitration against 3D Medicines on July 24, 2026 - SEC filing
- Sellas Life Sciences Group - Company to pay about $1 million of 3D Medicines' legal fees - SEC filing
- Sellas Life Sciences Group Inc: 3D Medicines will continue development & commercialization of galinpepimut-S in Greater China territory
